Association of CDX2 and Mucin Expression with Chemotherapeutic Benefits in Patients with Stage II/III Gastric Cancer

0
201
Scientists assessed the ability of CDX2 and mucin markers to predict prognosis and fluorouracil-based adjuvant chemotherapy benefits.
[Cancer Medicine]
Full Article